Clinical Trials · NCT00803920
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- HealthPartners Institute
- Enrollment
- 8
- Start date
- Dec 2006
- Locations
- 1 site, United States
- Primary endpoint
- Characterize glucose control using periodic CGM in subjects participating in protocol 2993LAR-105 at the International Diabetes Center study site.